Clinical Effect of Electroacupuncture on Postoperative Analgesia After Cesarean Sectionanalgesia After Cesarean Section
NCT ID: NCT04879212
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
158 participants
INTERVENTIONAL
2021-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cesarean Rate in Parturients Without Neuraxial Analgesia
NCT01157325
The Comparison Of Nerve Blocks In Cesarean Delivery
NCT03333902
Transcutaneous Electrical Acupoint Stimulation on Gastrointestinal Function After Cesarean Section
NCT02416310
Continuous Infusion for Pain Relief
NCT02711072
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
NCT04399707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
2. PCIA +2 Hz Electroacupuncture group
3. PCIA +20/100 Hz Electroacupuncture group
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCIA +Acupuncture group
Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6) to connect Huatuo brand electroacupuncture apparatus, but no electricity. Acupuncture was given once a day. PCIA(patient controlled intravenous analgesia).
PCIA +Acupuncture group:
Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)
PCIA +2 Hz Electroacupuncture group
Acupuncture bilateral Zusanli (ST36) and Sanyinjiao (SP6) to connect Huatuo brand electroacupuncture apparatus, and the ipsilateral Zusanli, Sanyinjiao were respectively connected as a loop. The parameters of electroacupuncture were set as 2Hz, continuous wave, 25min, and current intensity was 0.1-5.0mA. Acupuncture was given once a day.
PCIA +Acupuncture group:
Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)
PCIA +20/100 Hz Electroacupuncture group
Acupuncture bilateral Zusanli (ST36) and Sanyinjiao (SP6) to connect Huatuo brand electroacupuncture apparatus, and the ipsilateral Zusanli, Sanyinjiao were respectively connected as a loop. The parameters of electroacupuncture were set as 20 / 100Hz, density wave, 25min, and current intensity was 0.1-5.0mA. Acupuncture was given once a day.
PCIA +Acupuncture group:
Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PCIA +Acupuncture group:
Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* There was no electroacupuncture treatment before cesarean section;
* No food and drug allergy, no long-term use of analgesics; .They agreed and only participated in one clinical project and signed the informed consent form.
Exclusion Criteria
* There was a history of chronic pain before operation;
* History of cognitive impairment;
* Skin lesions such as ulcers and eczema at the needling site are not suitable for needling;
22 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ying Jin
Role: PRINCIPAL_INVESTIGATOR
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-1029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.